Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children’s Oncology Group phase 1 consortium study

BACKGROUND: Various human cancers have ALK gene translocations, amplifications, or oncogenic mutations, such as anaplastic large-cell lymphoma, inflammatory myofibroblastic tumours, non-small-cell lung cancer (NSCLC), and neuroblastoma. Therefore, ALK inhibition could be a useful therapeutic strateg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mossé, Yael P, Lim, Megan S, Voss, Stephan D, Wilner, Keith, Ruffner, Katherine, Laliberte, Julie, Rolland, Delphine, Balis, Frank M, Maris, John M, Weigel, Brenda J, Ingle, Ashish M, Ahern, Charlotte, Adamson, Peter C, Blaney, Susan M
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730818/
https://ncbi.nlm.nih.gov/pubmed/23598171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(13)70095-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados